9574 Ratios - Professional Medical Expertise Co. | premargin

Sign In Sign Upعربي

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual Quarterly

Ratios

1-5

	H2 2025Dec 31, 2025	H1 2025Jun 30, 2025	H2 2024Dec 31, 2024	H1 2024Jun 30, 2024	H2 2023Dec 31, 2023
Market & Price
Market Capitalization	339.50M	308.00M	314.65M	280.00M	250.25M
Market Cap Growth	+7.9%	+10.0%	+25.7%	—	—
Enterprise Value	443.30M	396.91M	408.61M	343.41M	321.49M
Last Close Price	97.00	88.00	88.85	79.07	67.81
Valuation Multiples
PE Ratio	8.14	8.18	11.38	10.08	10.07
PS Ratio	0.81	0.87	1.01	1.01	1.00
PB Ratio	2.26	2.34	2.78	2.82	2.58
P/TBV Ratio	2.26	2.34	2.78	2.82	2.58
P/FCF Ratio	—	—	-37.21	—	-80.75
P/OCF Ratio	—	23.10	-167.36	—	42.56
EV/Sales Ratio	1.06	1.12	1.31	1.23	1.29
EV/EBITDA Ratio	6.71	7.28	9.24	8.42	8.68
EV/EBIT Ratio	7.42	8.08	10.38	9.46	9.72
EV/FCF Ratio	—	—	-48.33	—	-103.74
Leverage & Capital
Debt / Equity Ratio	0.84	0.84	0.83	1.02	0.66
Debt / FCF Ratio	—	—	-11.10	—	-20.77
Net Debt / Equity Ratio	0.81	0.79	0.79	0.95	0.65
Net Debt / EBITDA Ratio	1.85	1.91	2.01	2.30	1.71
Net Debt / FCF Ratio	-5.18	-80.09	-10.52	-16.84	-20.46
Returns & Yields
Return on Capital Employed (ROCE)	+35.6%	+33.2%	+31.0%	+32.8%	+30.6%
Earnings Yield	+12.3%	+12.2%	+8.8%	+9.9%	+9.9%
FCF Yield	-6.9%	-0.4%	-2.7%	-2.0%	-1.2%
Buyback Yield / Dilution	—	—	—	—	+0.8%
Total Shareholder Return	—	—	—	—	+0.8%